In the present work, we demonstrated that EGFR mutations enhance the tumor expression of TGF-β, which contributes to the suppression of CD8+ T cell infiltration, proliferation, and cytotoxicity in the TME. This evidence concerns the gene TGFB1 and neoplasm.